Latest Ratios: P/E Ratio 69.5x · EV/EBITDA N/A · ROE 3.9%. (2024–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Market Cap | $271M | $185M | — |
| Enterprise Value | $270M | $184M | — |
| P/E Ratio → | 69.53 | 69.00 | — |
| P/S Ratio | — | — | — |
| P/B Ratio | 0.99 | 0.99 | — |
| P/FCF | — | — | — |
| P/OCF | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| EV / Revenue | — | — | — |
| EV / EBITDA | — | — | — |
| EV / EBIT | — | — | — |
| EV / FCF | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Gross Margin | — | — | — |
| Operating Margin | — | — | — |
| Net Profit Margin | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| ROE | 3.9% | 3.9% | — |
| ROA | 3.7% | 3.7% | -4.8% |
| ROIC | -2.9% | -2.9% | — |
| ROCE | -3.7% | -3.7% | -11.2% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Debt / Equity | — | — | — |
| Debt / EBITDA | — | — | — |
| Net Debt / Equity | — | -0.01 | — |
| Net Debt / EBITDA | — | — | — |
| Debt / FCF | — | — | — |
| Interest Coverage | — | — | — |
Net cash position: cash ($984245) exceeds total debt ($0)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Current Ratio | 4.06 | 4.06 | 0.07 |
| Quick Ratio | 4.06 | 4.06 | 0.07 |
| Cash Ratio | 3.01 | 3.01 | 0.04 |
| Asset Turnover | — | — | — |
| Inventory Turnover | — | — | — |
| Days Sales Outstanding | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Dividend Yield | — | — | — |
| Payout Ratio | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Earnings Yield | 1.4% | 1.4% | — |
| FCF Yield | — | — | — |
| Buyback Yield | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | — | — |
| Shares Outstanding | — | $18M | $26M |
Execution and Liquidation Risk
According to recent financial data, HVII trades at a P/B of 0.99, which suggests that the market is pricing the entity near its liquidation value rather than assigning any premium for the sponsor's ability to source a high-quality industrial target in the current environment.
The P/E ratio of 69.53 is largely irrelevant given the absence of operational revenue and the distortive impact of non-operating accounting adjustments. Investors should interpret this valuation as a reflection of the trust's cash backing rather than an assessment of future earnings potential, as the company lacks a traditional business model to justify growth-oriented multiples.
Based on reported figures, the company's ROIC has trended into negative territory, reaching -0.4% in 2026Q1, which illustrates the ongoing erosion of invested capital as administrative costs continue to accumulate without any offsetting operational returns or business combination progress to drive value creation.
The consistent decline in ROE and ROIC highlights the structural inefficiency of the SPAC model during the search phase. This trend suggests that capital is being consumed by fixed overhead rather than being deployed effectively, which warrants further investigation into the sponsor's ability to preserve shareholder value before the trust deadline.
As reported in financial statements, the current ratio has compressed from 15.21 in 2025Q1 to 6.82 in 2026Q1, indicating that the company's ability to cover its short-term administrative liabilities is weakening as the search for a target extends and cash reserves are steadily depleted.
While a current ratio of 6.82 appears superficially healthy, it masks the reality that these assets are largely restricted or earmarked for eventual acquisition, leaving little room for operational error. Investors should monitor this downward trend, as it suggests that the company's financial flexibility is diminishing, potentially forcing a sub-optimal deal or liquidation.
The most commonly misapplied metric for HVII is the P/E ratio, which fails to account for the fact that the company is a pre-revenue vehicle where net income is driven by non-cash accounting adjustments rather than operational performance or sustainable business growth.
Analysts should instead focus on the 'Redemption Rate' and 'Cash-on-Hand' relative to the 'Time to Expiration' to gauge the true viability of the entity. Relying on traditional valuation multiples like P/E or EV/EBITDA in this context is misleading, as it ignores the binary nature of the SPAC structure and the significant off-balance-sheet liabilities that only crystallize upon a successful merger.
Includes 30+ ratios · 2 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying HVII stock.
Hennessy Capital Investment Corp. VII's current P/E ratio is 69.5x. The historical average is 69.0x. This places it at the 100th percentile of its historical range.
Hennessy Capital Investment Corp. VII's return on equity (ROE) is 3.9%. The historical average is 3.9%.
Based on historical data, Hennessy Capital Investment Corp. VII is trading at a P/E of 69.5x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.